Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 20 min ago
Peer-reviewedLicence not statedJAMA Psychiatry

Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness

  • Roger S. McIntyre1,2,3
  • Yanli Zhang-James4
  • Angela T. H. Kwan3,5
5 affiliations
  1. 1Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
  2. 2Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
  3. 3Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada
  4. 4Department of Psychiatry and Behavioral Sciences, Norton College of Medicine at State University of New York, Upstate Medical University, Syracuse
  5. 5Department of Internal Medicine, University of Toronto, Toronto, Ontario, Canada
Read full textDOICite

Related

  1. Cardiovascular Outcomes in Patients with Type 2 Diabetes and Heart Failure with Reduced Ejection using Glucagon-like Peptide-1 Receptor Agonists
    M. Al-Nusair, A. Maini, S. Khurana +1
    medRxivPreprintCC BYFull textCardiovascular medicinemedRxiv
  2. Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
    Alaa Solaiman Algazzar
    Saudi Journal of Internal MedicinePeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
  3. Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity
    Samuel B. Governor, David M. Dávila‐García, Eliut Rivera‐Segarra +7
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDEndocrinology & metabolismCrossref
  4. Association of Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors with Tuberculosis and Mortality in Adults with Diabetes
    Chun-Hsiang Hsu, Renin Chang, Chiu-Fan Chen +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMC
  5. Glucagon-Like Peptide-1 Receptor Agonists and the Eye: Ocular Safety, Retinal Outcomes, and Clinical Implications
    Gwi Eun Yeo, Joonhyung Kim
    Journal of Korean medical sciencePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{mcintyre2026glucagonlike,
  title = {{Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness}},
  author = {Roger S. McIntyre and Yanli Zhang-James and Angela T. H. Kwan},
  journal = {JAMA Psychiatry},
  year = {2026},
  month = aug,
  doi = {10.1001/jamapsychiatry.2026.2574},
  url = {https://doi.org/10.1001/jamapsychiatry.2026.2574},
}
RIS
TY  - JOUR
TI  - Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness
AU  - Roger S. McIntyre
AU  - Yanli Zhang-James
AU  - Angela T. H. Kwan
PY  - 2026
DA  - 2026/08/26
JO  - JAMA Psychiatry
DO  - 10.1001/jamapsychiatry.2026.2574
UR  - https://doi.org/10.1001/jamapsychiatry.2026.2574
SN  - 2168-622X
SN  - 2168-6238
ER  -